Citroma Liquid
NDC Package 11673-708-38
Package Information
Citroma (magnesium citrate) liquids is a medication used to clean stool from the intestines before surgery or certain bowel procedures (e.g., colonoscopy, radiography), usually with other products. This formulation utilizes a liquid delivery system. Marketed by Target Corporation, this product is identified by NDC 11673-708 and is authorized under FDA application M007.
Identification & Billing
Clinical Specifications
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 11673 - Target Corporation
- 11673-708 - Citroma
- 11673-708-38 - 296 mL in 1 BOTTLE, PLASTIC
- 11673-708 - Citroma
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 11673-708-38 identifies a specific commercial package of 296 ml in 1 bottle, plastic of Citroma, a human over the counter drug labeled by Target Corporation. This liquid is formulated for oral use and contains magnesium citrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Target Corporation on February 18, 2018. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This product is used to clean stool from the intestines before surgery or certain bowel procedures (e.g., colonoscopy, radiography), usually with other products. It may also be used for relief of constipation. However, milder products (e.g., stool softeners, bulk-forming laxatives) should be used whenever possible for constipation. Magnesium citrate is a saline laxative that is thought to work by increasing fluid in the small intestine. It usually results in a bowel movement within 30 minutes to 3 hours.
How is this Target Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 11673070838. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.